NCT06135571 Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer
| NCT ID | NCT06135571 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
| Condition | Colorectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2024-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2023-09-01 with a primary completion date of 2024-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about the the pattern of metastasis of the No.253 lymph node in colorectal cancer. The main questions it aims to answer are: 1. What are the risk factors for metastasis to the No.253 lymph node? 2.What is the prognosis for patients with metastasis to the No.253 lymph node? Patients with descending colon cancer, sigmoid colon cancer, and rectal cancer who undergo curative surgery with dissection of the No.253 lymph node are included in this study
Eligibility Criteria
Inclusion Criteria: 1. Age: 18-75 years; 2. Underwent laparoscopic left hemicolectomy, sigmoid colectomy, or rectal cancer radical surgery. 3. Postoperative pathology confirmed as adenocarcinoma. 4. No evidence of distant metastasis. Exclusion Criteria: 1. Previous history of malignant colorectal tumors. 2. Patients who have undergone multiple abdominal-pelvic surgeries. 3. Patients undergoing emergency surgery due to complications such as intestinal obstruction, intestinal perforation, or intestinal bleeding. 4. Surgery did not achieve R0 resection. 5. Patients with concurrent other malignant tumors or multiple primary colorectal cancers. 6. Patients unwilling to sign an informed consent or follow the study protocol for follow-up.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06135571 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06135571 currently recruiting?
Yes, NCT06135571 is actively recruiting participants. Contact the research team at fcwpumch@163.com for enrollment information.
Where is the NCT06135571 trial being conducted?
This trial is being conducted at Beijing, China, Beijing, China, Beijing, China, Beijing, China.
Who is sponsoring the NCT06135571 clinical trial?
NCT06135571 is sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.